Zhongguancun (000931.SZ) announcement. Recently, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued “On India...
Zhitong Finance App News, Zhongguancun (000931.SZ) announced that recently, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “Notice on<国家基本医疗保险、工伤保险和生育保险药品目录> Issuance” [Health Insurance [2023] No. 30]. Beijing Huasu Pharmaceutical Co., Ltd. (“Beijing Huasu”), the holding subsidiary of the company's wholly-owned subsidiary Beijing Zhongguancun Sihuan Pharmaceutical Co., Ltd. (“Beijing Huasu”) and Sihuan Pharmaceutical have many holding subsidiaries Drugs belonging to Pharmaceutical Co., Ltd. (“Duoduo Pharmaceutical”) were selected in the “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2023)”, and a total of 34 of the company's products were selected in the “Medical Insurance Catalogue 2023", including: the core product, benidipine fumarate tablets, and potential varieties of oxycodone hydrochloride tablets, naloxone hydrochloride injections, etc., which have entered the 2022 national medical insurance catalogue.